This site uses cookies to improve your experience. By viewing our content, you are accepting the use of cookies. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country we will assume you are from the United States. View our privacy policy and terms of use.

Remove 2024 Remove Medical science Remove Safety Related Topics
Healthcare Provider Food and Drug Administration Prospecting Competition Patients Sales FDA Leads Healthcare Management More Related Topics >
article thumbnail

Leveraging innate cell engagers for lymphoma treatment

European Pharmaceutical Review

DECEMBER 28, 2023

We have now already treated the first patients and are expecting the first results from this study in the first half of 2024.  These efficacy results, combined with the safety profile that allows patients to complete their treatment regimen, are extremely encouraging. What were two key findings from the investigational study?

Food and Drug Administration 84
Food and Drug Administration Patients Safety Medical science 84
article thumbnail

It’s Time We Got the Most Out of Medical Affairs Data

PM360

MARCH 22, 2024

Field Medical Affairs is an essential bridge between pharmaceutical clinical development and commercial delivery. Historically, the industry has left MSL-HCP interactions to exist on their own, focusing on objective metrics and key performance indicators (KPIs) to inform Medical Affairs impact.

Medical 52
Medical Education Medical science Sales 52
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

 

Stay Connected

Join 8,000+ Insiders by signing up for our newsletter

About
About
Editions
Editions
Topics
Powered by Aggregage | Terms and Conditions | Your California Rights and Privacy Policy
© Aggregage 2024